Home/Filings/4/0001140361-07-024880
4//SEC Filing

LYONDELL CHEMICAL CO 4

Accession 0001140361-07-024880

CIK 0000842635operating

Filed

Dec 19, 7:00 PM ET

Accepted

Dec 20, 2:03 PM ET

Size

21.6 KB

Accession

0001140361-07-024880

Insider Transaction Report

Form 4
Period: 2007-12-20
GELB MORRIS
Executive Vice President & COO
Transactions
  • Disposition to Issuer

    Common Stock

    2007-12-20$48.00/sh102,216$4,906,368140,471 total
  • Disposition to Issuer

    Common Stock

    2007-12-20140,4710 total
  • Award

    Common Stock

    2007-12-20+102,216242,687 total
  • Disposition to Issuer

    Common Stock

    2007-12-2014,6770 total(indirect: By 401(k))
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2007-12-20$23.48/sh60,034$1,409,5980 total
    Exercise: $24.52Exp: 2016-02-23Common Stock (60,034 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2007-12-20$16.03/sh98,367$1,576,8230 total
    Exercise: $31.97Exp: 2017-02-22Common Stock (98,367 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2007-12-20$19.44/sh22,057$428,7880 total
    Exercise: $28.56Exp: 2015-01-20Common Stock (22,057 underlying)
  • Disposition to Issuer

    Phantom Stock

    2007-12-20$48.00/sh21,310$1,022,8800 total
    Common Stock (21,310 underlying)
Footnotes (7)
  • [F1]This reports the payout of performance awards denominated in shares of Lyondell?s common stock, on the effective date of the merger pursuant to the Merger Agreement between Lyondell and Basell and BIL Acquisition Holdings Limited (?Merger Agreement?) for the merger consideration of $48 per share.
  • [F2]Includes shares accumulated in the Company's Dividend Reinvestment Plan.
  • [F3]Shares of common stock disposed of on the effective date of the merger pursuant to the Merger Agreement for the merger consideration of $48 per share.
  • [F4]The options, which 2/3 vested ratably on January 20, 2006 and January 20, 2007 and 1/3 vested on November 20, 2007 in connection with shareholder approval of the merger, were canceled pursuant to the Merger Agreement in exchange for a cash payment of $428,788.08 representing the difference between the exercise price of the option and the $48 per share merger consideration.
  • [F5]The options, which 1/3 vested on February 23, 2007 and the remaining 2/3 on the effective date of the merger, were canceled pursuant to the Merger Agreement in exchange for a cash payment of $1,409,598.32 representing the difference between the exercise price of the option and the $48 per share merger consideration.
  • [F6]The options, which vested on the effective date of the merger, were canceled pursuant to the Merger Agreement in exchange for a cash payment of $1,576,823.01 representing the difference between the exercise price of the option and the $48 per share merger consideration.
  • [F7]Phantom Stock which convert on a 1 for 1 basis and provided for vesting in 3 equal annual installments beginning one year from the date of grant, was disposed of on the effective date of the merger pursuant to the Merger Agreement for the merger consideration of $48 per share.

Documents

1 file

Issuer

LYONDELL CHEMICAL CO

CIK 0000842635

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000842635

Filing Metadata

Form type
4
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 2:03 PM ET
Size
21.6 KB